Results 181 to 190 of about 98,145 (299)

Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5240-5251, June 2026.
ABSTRACT Aims Although the American Diabetes Association (ADA) recently established a diagnostic algorithm for the early detection of liver fibrosis among high‐risk individuals, its implications for chronic kidney disease (CKD) risk stratification remain unclear.
Chan‐Young Jung, Hye Won Lee, Jung Il Lee, Han Ah Lee, Seung Up Kim   +4 more
wiley   +1 more source

Prevalence-Guided Anti-HCV and Reflex HCV Ag Testing in the Detection of Patients with Chronic Hepatitis C in Hepatitis C Endemic Areas. [PDF]

Diagnostics (Basel)
Chen SH, Ding YJ, Hsu NT, Chang TS, Lin YC, Chao WH, Lu SN.   +6 more
europepmc   +1 more source

The prevalence of HCV RNA positivity in anti-HCV antibodies-negative hemodialysis patients in Thrace Region. Multicentral study. [PDF]

Germs, 2021
Konstantinidou EI, Kontekaki EG, Kefas A, Konstantinidis T, Romanidou G, Fotiadou E, Rekari V, Triantafyllidou E, Zisaki S, Kasmeridou E, Andreadou M, Kantartzi K, Mavromatidis K, Martinis G, Cassimos D, Thodis E, Panopoulou M, Mimidis K.   +17 more
europepmc   +1 more source

A Framework for Emergency Department–Integrated Hepatitis C Test‐and‐Treat in the United States

Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Despite the availability of curative, direct‐acting antiviral therapy, hepatitis C virus elimination remains incomplete. Losses across the care cascade continue to limit impact, from initial diagnosis to sustained virologic response. Fewer than 1/3 of individuals ultimately achieve cure. These gaps reflect a delivery system that does not align
Saeed S. Graham
wiley   +1 more source

New anti HCV drugs in the pipeline

Retrovirology, 2010
Bourlière Marc
doaj   +1 more source

Screening for anti-HCV antibodies in a cohort of people living with HIV at "Zia Angelina" Medical Centre, Kampala, Uganda. [PDF]

Pan Afr Med J
De Maria F, González FR, Namuwonge AJ, Serraino R, Torti C.   +4 more
europepmc   +1 more source

Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’

Vox Sanguinis, EarlyView.
Ramune Sepetiene, Mohamed Ali, Guillermo Orjuela, Ted Kieffer, Ellen Ollson, Axel Stover, Jason Kang   +6 more
wiley   +1 more source

Resolved HBV Infection Is Not Associated With Liver‐Related Outcomes in Survival Analysis of Caucasians After HCV Cure

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background Previous exposure to hepatitis B virus (HBV) may influence the risk of developing hepatocellular carcinoma (HCC) and other liver‐related events (LRE), in particular in patients after HCV cure. Previous studies were not conclusive and there are only few large studies on this topic from Europe. Methods We analysed clinical endpoints (≥
Laura Muana Wilhelm, Albrecht Stoehr, Peter Buggisch, Christine John, Ralph Link, Hartwig Klinker, Uta Merle, Markus Cornberg, Christoph Sarrazin, Thomas Berg, Heiner Wedemeyer   +10 more
wiley   +1 more source

Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma. [PDF]

Liver Int
Giannini EG, Pasta A, Plaz Torres MC, Pieri G, Cabibbo G, Sangiovanni A, Piscaglia F, Campani C, Missale G, Vidili G, Ghittoni G, Pelizzaro F, Foschi FG, Morisco F, Santi V, Svegliati-Baroni G, Azzaroli F, Saitta C, Brunetto MR, Sacco R, Ponziani FR, Boninsegna S, Nardone G, Martini A, Mega A, Sacerdoti D, Magalotti D, Vitale A, Bucci L, Trevisani F, Italian Liver Cancer (ITA.LI.CA) group.   +30 more
europepmc   +1 more source

[Application of anti-HCV and HCV RNA detection in intravenous drug users]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2021
Xu B, Chen B, Ma ZH, Ren YN, Ma JQ, Pei LJ, Xing WW.   +6 more
europepmc   +1 more source